Clinical trial
Sandostatin LAR vs. Surgery in Acromegalics With Macroadenoma
NCT00001860 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sandostatin LAR vs. Surgery in Acromegalics With Macroadenoma
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 1999
- Completion date
- July 31, 2002
- Enrollment
- 5
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acromegaly, pituitary neoplasm